“…Immunocytochemistry was performed as described (Kouznetsova et al, 2005) using a 'drying-down' technique (Peters et al, 1997) and the following antibodies: rabbit anti-SYCP1 (1:50) (Liu et al, 1996), mouse anti-SYCP1 (1:200) (gift from C. Heyting, Wageningen, The Netherlands,), rabbit anti-SYCP3 (1:200) (Liu et al, 1996), human anti-CREST (1:1500) (Hadlaczky et al, 1986), rabbit anti-STAG3 (1:400) (Pezzi et al, 2000), guinea pig anti-STAG3 (1:200) (Kouznetsova et al, 2005), guinea pig anti-SYCE1 (1:1500) (Hamer et al, 2006), guinea pig anti-SYCE2 (1:400) (Hamer et al, 2006), rabbit anti-γ-H2AX (Upstate Biotechnology) (1:100), rabbit anti-BRCA1 (gift from J. M. A. Turner, National Institute for Medical Research, London, UK) (1:1000), rabbit anti-DMC1 (1:100) and rabbit anti-RPA (1:500) (gifts from P. Moens, York University, Toronto, Canada) and mouse anti-MLH1 (1:50) (BD Biosciences). Secondary antibodies were applied as described (Kouznetsova et al, 2005;Wang and Hoog, 2006).…”